Markets
Stocks
Mutual Funds & ETF's
Sectors
Tools
Overview
Market News
Currencies
International
Search InvestCenter
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Top Indices
DJI
Nasdaq Composite
SPX
My Portfolio
Novavax Inc
(NQ:
NVAX
)
13.30
+1.16 (+9.56%)
Streaming Delayed Price
Updated: 4:00 PM EDT, Sep 27, 2024
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
All News about Novavax Inc
< Previous
1
2
...
29
30
31
32
33
34
35
36
37
...
59
60
Next >
Novavax Revenue Guidance Does Little to Change Neutral Stance on the Stock
March 04, 2022
NVAX stock's revenue guidance may have given investors a reason to stay invested. However, risks continue to outweigh benefits.
Via
InvestorPlace
10 Biggest Price Target Changes For Thursday
March 03, 2022
Piper Sandler cut the price target on Bright Health Group, Inc. (NYSE: BHG) from $10 to $5. Bright Health shares rose 3.2% to $2.59 in pre-market trading.
Via
Benzinga
Russia’s Aggression Could Put a Damper on Novavax Global Vax Deployment
March 02, 2022
The best chance for profits with NVAX stock is with the international market. But Russia's invasion of Ukraine could put Novavax's strategy at risk.
Via
InvestorPlace
44 Stocks Moving In Tuesday's Mid-Day Session
March 01, 2022
Gainers Avenue Therapeutics, Inc. (NASDAQ: ATXI) climbed 193% to $0.9962 after jumping 36% on Monday. GBS Inc. (NASDAQ: GBS) rose 73.3% to $0.7971 after declining around 9% on...
Via
Benzinga
Earnings Scheduled For February 28, 2022
February 28, 2022
Companies Reporting Before The Bell • Lexicon Pharmaceuticals (NASDAQ:LXRX) is estimated to report earnings for its fourth quarter. • Praxis Precision Medicine (...
Via
Benzinga
Is Now The Time To Buy Stock In Novavax, Zoom Or Workhorse?
February 25, 2022
Analysts and brokerage firms often use ratings when they issue stock recommendations to stock traders. Analysts arrive at stock ratings b...
Via
Benzinga
What's Going On With Novavax Shares Today?
March 01, 2022
Novavax Inc (NASDAQ: NVAX) is trading higher Tuesday after the company reported fourth-quarter financial results and issued guidance expecting a surge in revenue. Novavax reported...
Via
Benzinga
Novavax Expects At Least $4 Billion In Covid Vaccine Sales This Year; Shares Pop
March 01, 2022
The company missed fourth-quarter expectations, however.
Via
Investor's Business Daily
27 Stocks Moving in Monday's Pre-Market Session
March 01, 2022
Gainers Avenue Therapeutics, Inc. (NASDAQ: ATXI) rose 123.4% to $0.76 in pre-market trading after jumping 36% on Monday. American Rebel Holdings, Inc. (NASDAQ: AREB) rose 28.6...
Via
Benzinga
My Top Things To Expect This Week
February 28, 2022
This week will bring earnings that give insight into multiple investment themes and other important events that you should watch out for.
Via
InvestorPlace
Novavax Stock’s Wild Moves Leave Little Room for Error
February 22, 2022
NVAX stock can still bring profits for traders and investors as long as they are willing to accept the risks that it brings.
Via
InvestorPlace
Why I’m Done With Novavax Stock
February 15, 2022
Management is terrible at delivering on its promises and even good news has failed to translate into higher prices for NVAX stock.
Via
InvestorPlace
Novavax: Q4 Earnings Insights
February 28, 2022
Novavax (NASDAQ:NVAX) reported its Q4 earnings results on Monday, February 28, 2022 at 04:05 PM. Here's what investors need to know about the announcement. Earnings Novavax...
Via
Benzinga
The Week Ahead In Biotech (Feb. 27-March 5): Earnings, Multiple Regulatory Decisions Take The Spotlight
February 27, 2022
Biopharma stocks lock-stepped with the broader market in the week ending Feb. 25 before finishing higher. The trajectory was the same, with the sector declining in the first...
Via
Benzinga
Moderna’s Covid Shot Alone Isn’t Enough to Revitalize a Sagging Stock
February 25, 2022
Moderna has to focus on the rest of its pipeline to keep MRNA stock relevant and profitable as Covid vaccine revenues taper off by 2023.
Via
InvestorPlace
Novavax: The Frustration Is Real, And So Is the Sales Potential
February 25, 2022
All isn't well with NVAX stock, but it is very close to rallying. The results could give Novavax a boost and push the stock high.
Via
InvestorPlace
Novavax Is a Buy on Recent Developments and Cheap Valuation
February 24, 2022
NVAX stock is one of the major players in the vaccine market, which is one that is expected to grow substantially over the next few years.
Via
InvestorPlace
4 Pharma Stocks to Buy Even if the Pandemic Ends
February 24, 2022
Here are four pharma stocks that looks attractive for the long-term. Deep product development pipelines will ensure steady revenue and cash flow growth.
Via
InvestorPlace
10 Health Care Stocks With Whale Alerts In Today's Session
February 23, 2022
This whale alert can help traders discover the next big trading opportunities. Whales are entities with large sums of money and we track their transactions here at Benzinga on our options activity...
Via
Benzinga
Production Updates Could Give Novavax Stock a Big Boost
February 22, 2022
Given the low expectations for Novavax's deliveries, better-than-expected numbers could send the NVAX stock price back to the triple digits.
Via
InvestorPlace
Check Out What Whales Are Doing With NVAX
February 22, 2022
Someone with a lot of money to spend has taken a bearish stance on Novavax (NASDAQ:NVAX). And retail traders should know. We noticed this today when the big position showed up on publicly available...
Via
Benzinga
After Being Unloved on Wall Street, Novavax Deserves a Shot
February 22, 2022
NVAX stock was a darling of the markets once and could be again, given Novavax's recent progress in advancing Covid-19 vaccines globally.
Via
InvestorPlace
Why Novavax Has Limited Downside from Here
February 21, 2022
As countries potentially adopt a once yearly vaccination booster schedule for Covid-19, you can expect steady earnings for NVAX stock.
Via
InvestorPlace
Dump Novavax Stock as Delays May Make Its Vaccine Practically Obsolete
February 21, 2022
NVAX stock's price continues to slide lower as the prospects of its Covid-19 vaccine getting approved in the U.S. grow dim.
Via
InvestorPlace
Novavax's COVID-19 Vaccine Scores Canadian Approval
February 17, 2022
Health Canada approves Novavax Inc's (NASDAQ: NVAX) Nuvaxovid COVID-19 Vaccine in individuals 18 years of age and older. The vaccine, also known as NVX-...
Via
Benzinga
10 Health Care Stocks With Whale Alerts In Today's Session
February 17, 2022
This whale alert can help traders discover the next big trading opportunities. Whales are entities with large sums of money and we track their transactions here at Benzinga on our options activity...
Via
Benzinga
This Reopening Stock Has A Better 1-Year Return Than Moderna, Pfizer, BioNTech, Novavax And Vaxart
February 17, 2022
Macy's Inc (NYSE:M) retail stores have something for everyo...
Via
Benzinga
Novavax Stock Is at Risk Despite Positive Poll Results
February 16, 2022
A recent poll supports Novavax's Covid treatment in the United States, but the vote on today's NVAX stock price chart warns against buying.
Via
InvestorPlace
Novavax Just Can’t Get it Together
February 16, 2022
Patient investors will wait for NVAX stock to hit another low or for the FDA to approve its Covid-19 vaccine before investing.
Via
InvestorPlace
Novavax Stock Has Growth Ahead Whether It Missed the Boat or Not
February 15, 2022
NVAX stock has been derided as a ran in the vaccine race, avoid that narrative and remain optimistic because the best is ahead for Novavax.
Via
InvestorPlace
< Previous
1
2
...
29
30
31
32
33
34
35
36
37
...
59
60
Next >
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.